BLK vs JNJ: Which Is the Better Buy?
Side-by-side comparison of BlackRock, Inc. and Johnson & Johnson — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-09-25.
BlackRock, Inc. · Financial Services
$1,069.78
+44.0% upside to fair value
High Conviction
Grade A
High Quality
VS
Johnson & Johnson · Healthcare
$270.68
+5.7% upside to fair value
Med Conviction
Grade C
High Quality
QuantHub Verdict
BLK has more upside to fair value
(+44.0%).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
BLK |
JNJ |
| Current Price |
$1,069.78 |
$270.68 |
| Fair Value Estimate |
$1,540.94 |
$286.05 |
| Upside to Fair Value |
+44.0%
|
+5.7%
|
| Market Cap |
$165.8B |
$652.3B |
| Forward P/E |
—
|
—
|
| EV / EBITDA |
15.9x
|
20.2x
|
| Price / Sales |
6.1x
|
6.7x
|
| Price / FCF |
71.5x
|
35.3x
|
| Revenue Growth YoY |
+30.6%
|
+6.6%
|
| Gross Margin |
55.7%
|
67.9%
|
| Operating Margin |
31.1%
|
26.8%
|
| Return on Equity |
11.7%
|
25.7%
|
| Dividend Yield |
2.09% |
1.95% |
| FCF Yield |
1.4%
|
2.83%
|
| Analyst Consensus |
Strong Buy
|
Buy
|
Investment Thesis
BlackRock is the world's largest asset manager, overseeing $15.345 trillion in assets across ETFs, active strategies, alternatives, and the Aladdin investment-technology platform, serving institutional, intermediary, and individual clients globally. The business quality is high: TTM gross margin of 55.7%, operating margin of 31.1%, and net margin of 24.1% reflect the scalability of a fee-based mo…
Johnson & Johnson is a 141,700-employee healthcare holding company operating two segments, Innovative Medicine (immunology, oncology, neuroscience, infectious disease, cardiovascular and metabolism, pulmonary hypertension) and MedTech (interventional solutions, orthopaedics, surgery, vision), founded in 1887 and headquartered in New Brunswick, New Jersey. Business quality is high on fundamentals:…
Accumulation Zones
| Metric |
BLK |
JNJ |
| Zone Low |
$1,155.70 |
$214.54 |
| Zone High |
$1,309.80 |
$243.14 |
| In Buy Zone? |
Yes
|
No
|